Diabetes

No Rise in Fracture Risk With SGLT2 Inhibition

Posted on: Sep 15, 2020   |   Posted by: Master Doctor

No Rise in Fracture Risk With SGLT2 Inhibition

Patients with type 2 diabetes who were treated second-line with sodium-glucose co-transporter-2 inhibitors, which can be associated with weight loss, did not have an increased...

Continue reading ...



Other Posts from Master Doctor